Neal A Chatterjee1,2, Jani T Tikkanen2,3, Gopi K Panicker4, Dhiraj Narula5, Daniel C Lee6, Tuomas Kentta3, Juhani M Junttila3, Nancy R Cook2, Alan Kadish7, Jeffrey J Goldberger8, Heikki V Huikuri3, Christine M Albert2,9. 1. Division of Cardiology, Department of Medicine, University of Washington, Seattle, USA. 2. Division of Preventive Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, 900 Commonwealth Avenue, Boston, MA 02215, USA. 3. Department of Cardiology, Research Unit of Internal Medicine, University Hospital of Oulu and University of Oulu, Oulu, Finland. 4. Cardiac Safety Services, Quintiles, Mumbai, India. 5. Mountainview Hospital, Las Vegas, NV, USA. 6. Department of Medicine, Division of Cardiology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA. 7. Department of Medicine, Division of Cardiology, Touro College and University System, New York, NY, USA. 8. Department of Medicine, Division of Cardiology, University of Miami Miller School of Medicine, Miami, FL, USA. 9. Department of Cardiology, Smidt Institute, Cedars Sinai Medical Center, Los Angeles, CA, USA.
Abstract
AIMS: To determine whether the combination of standard electrocardiographic (ECG) markers reflecting domains of arrhythmic risk improves sudden and/or arrhythmic death (SAD) risk stratification in patients with coronary heart disease (CHD). METHODS AND RESULTS: The association between ECG markers and SAD was examined in a derivation cohort (PREDETERMINE; N = 5462) with adjustment for clinical risk factors, left ventricular ejection fraction (LVEF), and competing risk. Competing outcome models assessed the differential association of ECG markers with SAD and competing mortality. The predictive value of a derived ECG score was then validated (ARTEMIS; N = 1900). In the derivation cohort, the 5-year cumulative incidence of SAD was 1.5% [95% confidence interval (CI) 1.1-1.9] and 6.2% (95% CI 4.5-8.3) in those with a low- and high-risk ECG score, respectively (P for Δ < 0.001). A high-risk ECG score was more strongly associated with SAD than non-SAD mortality (adjusted hazard ratios = 2.87 vs. 1.38 respectively; P for Δ = 0.003) and the proportion of deaths due to SAD was greater in the high vs. low risk groups (24.9% vs. 16.5%, P for Δ = 0.03). Similar findings were observed in the validation cohort. The addition of ECG markers to a clinical risk factor model inclusive of LVEF improved indices of discrimination and reclassification in both derivation and validation cohorts, including correct reclassification of 28% of patients in the validation cohort [net reclassification improvement 28 (7-49%), P = 0.009]. CONCLUSION: For patients with CHD, an externally validated ECG score enriched for both absolute and proportional SAD risk and significantly improved risk stratification compared to standard clinical risk factors including LVEF. CLINICAL TRIAL REGISTRATION: https://clinicaltrials.gov/ct2/show/NCT01114269. ClinicalTrials.gov ID NCT01114269. Published on behalf of the European Society of Cardiology. All rights reserved.
AIMS: To determine whether the combination of standard electrocardiographic (ECG) markers reflecting domains of arrhythmic risk improves sudden and/or arrhythmic death (SAD) risk stratification in patients with coronary heart disease (CHD). METHODS AND RESULTS: The association between ECG markers and SAD was examined in a derivation cohort (PREDETERMINE; N = 5462) with adjustment for clinical risk factors, left ventricular ejection fraction (LVEF), and competing risk. Competing outcome models assessed the differential association of ECG markers with SAD and competing mortality. The predictive value of a derived ECG score was then validated (ARTEMIS; N = 1900). In the derivation cohort, the 5-year cumulative incidence of SAD was 1.5% [95% confidence interval (CI) 1.1-1.9] and 6.2% (95% CI 4.5-8.3) in those with a low- and high-risk ECG score, respectively (P for Δ < 0.001). A high-risk ECG score was more strongly associated with SAD than non-SAD mortality (adjusted hazard ratios = 2.87 vs. 1.38 respectively; P for Δ = 0.003) and the proportion of deaths due to SAD was greater in the high vs. low risk groups (24.9% vs. 16.5%, P for Δ = 0.03). Similar findings were observed in the validation cohort. The addition of ECG markers to a clinical risk factor model inclusive of LVEF improved indices of discrimination and reclassification in both derivation and validation cohorts, including correct reclassification of 28% of patients in the validation cohort [net reclassification improvement 28 (7-49%), P = 0.009]. CONCLUSION: For patients with CHD, an externally validated ECG score enriched for both absolute and proportional SAD risk and significantly improved risk stratification compared to standard clinical risk factors including LVEF. CLINICAL TRIAL REGISTRATION: https://clinicaltrials.gov/ct2/show/NCT01114269. ClinicalTrials.gov ID NCT01114269. Published on behalf of the European Society of Cardiology. All rights reserved.
Authors: E William Hancock; Barbara J Deal; David M Mirvis; Peter Okin; Paul Kligfield; Leonard S Gettes; James J Bailey; Rory Childers; Anton Gorgels; Mark Josephson; Jan A Kors; Peter Macfarlane; Jay W Mason; Olle Pahlm; Pentti M Rautaharju; Borys Surawicz; Gerard van Herpen; Galen S Wagner; Hein Wellens Journal: J Am Coll Cardiol Date: 2009-03-17 Impact factor: 24.094
Authors: Juha Perkiömäki; Derek V Exner; Olli-Pekka Piira; Katherine Kavanagh; Samuli Lepojärvi; Mario Talajic; Jarkko Karvonen; Francois Philippon; Juhani Junttila; Benoit Coutu; Heikki Huikuri Journal: Ann Noninvasive Electrocardiol Date: 2015-01-15 Impact factor: 1.468
Authors: Marie Bayer Elming; Jens C Nielsen; Jens Haarbo; Lars Videbæk; Eva Korup; James Signorovitch; Line Lisbeth Olesen; Per Hildebrandt; Flemming H Steffensen; Niels E Bruun; Hans Eiskjær; Axel Brandes; Anna M Thøgersen; Finn Gustafsson; Kenneth Egstrup; Regitze Videbæk; Christian Hassager; Jesper Hastrup Svendsen; Dan E Høfsten; Christian Torp-Pedersen; Steen Pehrson; Lars Køber; Jens Jakob Thune Journal: Circulation Date: 2017-09-06 Impact factor: 29.690
Authors: Neal A Chatterjee; M Vinayaga Moorthy; Julie Pester; Andi Schaecter; Gopi K Panicker; Dhiraj Narula; Daniel C Lee; Jeffrey J Goldberger; Alan Kadish; Nancy R Cook; Christine M Albert Journal: JAMA Cardiol Date: 2018-07-01 Impact factor: 14.676
Authors: Kenneth C Bilchick; Yongfei Wang; Alan Cheng; Jeptha P Curtis; Kumar Dharmarajan; George J Stukenborg; Ramin Shadman; Inder Anand; Lars H Lund; Ulf Dahlström; Ulrik Sartipy; Aldo Maggioni; Karl Swedberg; Chris O'Conner; Wayne C Levy Journal: J Am Coll Cardiol Date: 2017-05-30 Impact factor: 24.094
Authors: M Juhani Junttila; Antti M Kiviniemi; E Samuli Lepojärvi; Mikko Tulppo; Olli-Pekka Piira; Tuomas Kenttä; Juha S Perkiömäki; Olavi H Ukkola; Robert J Myerburg; Heikki V Huikuri Journal: Heart Rhythm Date: 2018-10 Impact factor: 6.343
Authors: Silvia G Priori; Carina Blomström-Lundqvist; Andrea Mazzanti; Nico Blom; Martin Borggrefe; John Camm; Perry Mark Elliott; Donna Fitzsimons; Robert Hatala; Gerhard Hindricks; Paulus Kirchhof; Keld Kjeldsen; Karl-Heinz Kuck; Antonio Hernandez-Madrid; Nikolaos Nikolaou; Tone M Norekvål; Christian Spaulding; Dirk J Van Veldhuisen Journal: Eur Heart J Date: 2015-08-29 Impact factor: 29.983
Authors: Derek V Exner; Katherine M Kavanagh; Michael P Slawnych; L Brent Mitchell; Darlene Ramadan; Sandeep G Aggarwal; Catherine Noullett; Allie Van Schaik; Ryan T Mitchell; Mariko A Shibata; Sajad Gulamhussein; James McMeekin; Wayne Tymchak; Gregory Schnell; Anne M Gillis; Robert S Sheldon; Gordon H Fick; Henry J Duff Journal: J Am Coll Cardiol Date: 2007-11-26 Impact factor: 24.094
Authors: Julia Ramírez; Antti Kiviniemi; Stefan van Duijvenboden; Andrew Tinker; Pier D Lambiase; Juhani Junttila; Juha S Perkiömäki; Heikki V Huikuri; Michele Orini; Patricia B Munroe Journal: J Am Heart Assoc Date: 2022-08-29 Impact factor: 6.106
Authors: Ramkumar V Venkateswaran; M V Moorthy; Neal A Chatterjee; Julie Pester; Alan H Kadish; Daniel C Lee; Nancy R Cook; Christine M Albert Journal: JACC Clin Electrophysiol Date: 2021-07-28